He writes: With publication last week of a strange article about the Gillberg affair by the British Medical Journal (BMJ), the dumbing-down is increasingly obvious (read the article and the responses - or at least those which were allowed). The upshot of this BMJ commissioned piece is that researchers faced with questions over the integrity of their data analysis should simply destroy that data. Great advice! News today adds to the concerns. The BMJ have apparently (yet again) declined to publish a paper (about ghostwriting and data misrepresentation of Paxil study 329) involving one of their advertisers (GSK) because "they feel they don't have the resources for the legal work required to check it all". That seems to have become a regular excuse.
I'm still scratching my head at the MHRA for sending me the link. Did they want me to attend the symposium?
It all smacks of one big game for the boys and it's high time this game was put to an end.
Fid
**This article will be sent to the MHRA.
I don't expect them to make any sort of comment on this either!
The Medicines and Healthcare products Regulatory Agency (MHRA) - The FDA's equivalent in the UK - need a thorough impartial investigation. Their own Chief Executive refuses to budge on his stance that Seroxat (Paxil) is safe.
See http://fiddaman.blogspot.com/ for more information